Immunohistochemical phenotyping of plasma cells in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia is comparable to flow cytometric techniques

Clinical Lymphoma, Myeloma and Leukemia

Volumn 11, Issue 1, 2011, Pages 96-98

  Howard, Matthew T ^a   Hodnefield, Janice ^a   Morice, William G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; CYCLIN D1; INTERFERON REGULATORY FACTOR 4; SYNDECAN 1; TRANSCRIPTION FACTOR PAX5;

ADULT; ANTIGEN EXPRESSION; BONE MARROW BIOPSY; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; PLASMA CELL; PLASMACYTOMA; WALDENSTROEM MACROGLOBULINEMIA;

EID: 79953677499     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.3816/CLML.2011.n.018     Document Type: Conference Paper

References (7)

1. de Tute RM, Jack AS, Child JA, et al. A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma. Leukemia 2007; 21:2046-9. (Pubitemid 47299981)
2. Morice WG, Chen D, Kurtin PJ, et al. Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstrom's macroglobulinemia. Mod Pathol 2009; 22:807-16.
3. Morice WG, Hanson CA, Kumar S, et al. Novel multi-parameter flow cytometry sensitively detects phenotypically distinct plasma cell subsets in plasma cell proliferative disorders. Leukemia 2007; 21:2043-6. (Pubitemid 47299980)
4. San Miguel JF, Vidriales MB, Ocio E, et al. Immunophenotypic analysis of Waldenstrom's macroglobulinemia. Sem Oncology 2003; 30:187-95.
5. Kurtin PJ, Hobday KS, Ziesmer S, et al. Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry. Am J Clin Path 1999; 112:319-29. (Pubitemid 30214770)
6. Ansell SM, Kyle RA, Reeder CB, et al. Diagnosis and management of Waldenstrom macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines. Mayo Clin Proc 2010; 85:824-33.
7. Remstein ED, Hanson CA, Kyle RA, et al. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells. Semin Oncol 2003; 30:182-6. (Pubitemid 36506306)